Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$201M Sell
5,238,395
-79,405
-1% -$3.21M 0.15% 152
2014
Q2
$216M Buy
5,317,800
+143,060
+3% +$5.89M 0.17% 142
2014
Q1
$212M Buy
5,174,740
+382,107
+8% +$14.5M 0.19% 118
2013
Q4
$183M Sell
4,792,633
-915,058
-16% -$31.5M 0.17% 138
2013
Q3
$189M Buy
5,707,691
+221,575
+4% +$7.19M 0.19% 115
2013
Q2
$168M Buy
+5,486,116
New +$182M 0.2% 99

Other funds holding ORCL

UBS's ORCL Position: Q3 2014 in Review

UBS reduced its Oracle (ORCL) stake by 1.5% in Q3 2014, selling an estimated $3.21M and leaving 5,238,395 shares worth $201M. The position accounts for 0.15% of the portfolio, ranked #152.

UBS first reported a position in ORCL in Q2 2013 and has held it in 6 quarters since. The position peaked at $216M in Q2 2014. 1,498 funds tracked by Wall St. Rank hold ORCL as of Q3 2014.

  • UBS held 5,238,395 shares of Oracle worth $201M as of Q3 2014.
  • UBS sold 79,405 Oracle shares in Q3 2014, an estimated $3.21M.
  • Oracle made up 0.15% of UBS's portfolio in Q3 2014, its #152 holding.
  • UBS first reported a position in Oracle in Q2 2013 and has held it in 6 quarters since.
  • UBS's Oracle position peaked at $216M in Q2 2014.
  • 1,498 funds tracked by Wall St. Rank held Oracle as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.